SCHEMBL21168543

SCHEMBL21168543

c1ccc(-c2cccc(-c3cccc(-c4cccc5c4-c4ccccc4C54c5ccccc5-c5c(-c6cccc(-c7cccc(-c8ccccc8)n7)c6)cccc54)c3)n2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
RAB9A P51151 1/20 0.48
PDK2 Q15119 9/20 0.39
ASIC3 Q9UHC3 1/20 0.39
ADORA2A P29274 2/20 0.36
ADORA1 P30542 2/20 0.36
MAPT P10636 3/20 0.35
LMNA P02545 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
ADORA3 P0DMS8 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
MAPK10 P53779 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
RARA P10276 1/20 0.35
RARB P10826 1/20 0.35
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21168538 0.91 PDK2 (0.40) MEN1KMT2ARAB9APDK2ADORA2A
SCHEMBL21168565 0.90 PDK2 (0.42) MEN1KMT2ARAB9APDK2ADORA2A
SCHEMBL21168536 0.90 MEN1 (0.39) MEN1KMT2ARAB9APDK2ADORA2A
SCHEMBL23873846 0.88 PDK2 (0.38) MEN1KMT2ARAB9APDK2ADORA2A
SCHEMBL17031673 0.88 PDK2 (0.38) MEN1KMT2ARAB9APDK2ADORA2A
SCHEMBL21168612 0.88 MEN1 (0.46) MEN1KMT2AADORA2AADORA1MAPT
SCHEMBL21578583 0.87 PDK2 (0.40) MEN1KMT2ARAB9APDK2ADORA2A
SCHEMBL22073950 0.87 PDK2 (0.40) MEN1KMT2ARAB9APDK2ADORA2A
SCHEMBL19383095 0.87 MEN1 (0.44) MEN1KMT2AADORA2AADORA1MAPT
SCHEMBL24647079 0.87 SMARCA2 (0.36) MEN1KMT2ARAB9APDK2ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230126748-A1 POLYMER, A COMPOSITION, AND AN ELECTROLUMINESCENT DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-04-27 US disclosed
US-20230126748-A1 POLYMER, A COMPOSITION, AND AN ELECTROLUMINESCENT DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-04-27 US disclosed
US-11233200-B2 Condensed cyclic compound, composition including the same, and organic light-emitting device including the condensed cyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2022-01-25 US disclosed
US-20200212306-A1 QUANTUM DOT ELECTROLUMINESCENCE DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-07-02 US disclosed
US-20190221746-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND SAMSUNG ELECTRONICS CO., LTD. (KR) 2019-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11233200-B2 Condensed cyclic compound, composition including the same, and organic light-emitting device including the condensed cyclic compound CRY1, CRY2, MCM4 MEN1 203/4885KMT2A 1648/4885RAB9A 3493/4885
US-20190221746-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND CRY1, CRY2, MCM4 MEN1 203/4885KMT2A 1648/4885RAB9A 3493/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.